Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$72.33 USD

72.33
2,168,722

+1.96 (2.79%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $72.35 +0.02 (0.03%) 4:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HSIC or CNMD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HSIC vs. CNMD: Which Stock Is the Better Value Option?

QIAGEN (QGEN) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

New product approvals, partnerships in the diagnostic solutions category and sustained success in other product areas are likely to have contributed to QIAGEN's (QGEN) growth.

3 Reasons to Add Catalent (CTLT) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Catalent (CTLT) owing to its slew of strategic deals and product launches.

Cardinal Health's (CAH) Unit Ties Up to Boost Diabetes Care

by Zacks Equity Research

Cardinal Health's (CAH) company, OptiFreight Logistics', recent collaboration with Journey Biosciences to help patients with respect to long-term diabetes care.

Here's Why You Should Retain Cooper Companies (COO) Stock Now

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from strength in its business segments.

Allscripts' (MDRX) New AI-Based Offering to Improve Patient Care

by Zacks Equity Research

Allscripts' (MDRX) latest AI-based scheduling application is expected to provide improved patient care as well as increase operational efficiencies of the healthcare system.

Quest Diagnostics (DGX) Enhances Lab Experience With Facility

by Zacks Equity Research

Quest Diagnostics (DGX) new facility is fully operational and will empower better health for the patients and clients in the seven states the lab serves.

COVID Test Demand to Aid Quest Diagnostics (DGX) Q3 Earnings

by Zacks Equity Research

In terms of strategic acquisitions, Quest Diagnostics (DGX) is likely to have secured high returns in Q3 from the acquisition of Mercy's outreach laboratory services business.

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Henry Schein (HSIC) Dental Sales Grow Globally Despite Pandemic

by Zacks Equity Research

Widespread network and channel mix along with favorable long-term trends in the dental business bode well for Henry Schein (HSIC).

Dexcom's (DXCM) G6 CGM System Gets Coverage in Manitoba

by Zacks Equity Research

Dexcom's (DXCM) CGM System is expected to simplify diabetes management due to increasing access to the life changing technology.

Reasons to Hold on to Inari Medical (NARI) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Inari Medical (NARI) owing to its focus on understanding the venous system and its commitment toward patient care.

Veeva Systems' (VEEV) Deal to Enhance Digital Clinical Trials

by Zacks Equity Research

Veeva Systems' (VEEV) partnership with Leo Pharma to significantly boost the clinical trial process for patients, sites and sponsors.

Here's Why You Should Hold on to NextGen (NXGN) Stock Now

by Zacks Equity Research

NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR. However, intense competition woes linger.

LabCorp (LH) Gets FDA's EUA for Combined Home Collection Kit

by Zacks Equity Research

The EUA for LabCorp's (LH) combined home collection kit can enable health-care providers to identify and treat individuals suspected of COVID-19 or influenza A/B infection.

Here's Why You Should Add Neogen (NEOG) to Your Portfolio Now

by Zacks Equity Research

Investors are optimistic about Neogen (NEOG) on strength in its Food Safety and Animal Safety business segments.

Reasons to Hold on to Veeva Systems (VEEV) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of product launches and robust product adoptions.

Here's Why You Should Retain CVS Health (CVS) Stock For Now

by Zacks Equity Research

Investors are optimistic about CVS Health (CVS) on growth in the company's specialty digital solutions and a bullish 2021 outlook.

Here's Why You Should Invest in Patterson Companies (PDCO) Stock

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and dental business.

Cardinal Health's (CAH) Unit to Aid Canadian Healthcare System

by Zacks Equity Research

Cardinal Health's (CAH) subsidiary to support the Canadian Healthcare system against COVID-19 with vaccination policy.

Veeva Systems' (VEEV) New Offering to Optimize Lab Operations

by Zacks Equity Research

Veeva Systems' (VEEV) Vault LIMS is expected to help manufacturers optimize lab management and significantly simplify their systems landscape via a unified suite of quality and lab applications.

Here's Why You Should Invest in West Pharmaceutical (WST) Now

by Zacks Equity Research

West Pharmaceutical (WST) continues to gain momentum on the back of strength in Proprietary Products business.

PacBio (PACB) Partners with ERGA, Boosts Biodiversity Research

by Zacks Equity Research

PacBio's (PACB) collaboration with ERGA will help scientists to take the first important step toward creating high-quality genetic maps of each plant and animal species in a reliable manner.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Masimo's (MASI) EMMA Capnography on Neonates Favored by New Study

by Zacks Equity Research

Masimo's (MASI) EMMA is likely to aid in maintaining an optimal range of PaCO2 in preterm infants undergoing mechanical ventilation in the neonatal intensive care unit.